{"id":"https://openalex.org/W4406680705","doi":"https://doi.org/10.1158/2767-9764.c.7635367","title":"Data from Targeting PRMT1 Reduces Cancer Persistence and Tumor Relapse in EGFR- and KRAS-Mutant Lung Cancer","display_name":"Data from Targeting PRMT1 Reduces Cancer Persistence and Tumor Relapse in EGFR- and KRAS-Mutant Lung Cancer","publication_year":2025,"publication_date":"2025-01-21","ids":{"openalex":"https://openalex.org/W4406680705","doi":"https://doi.org/10.1158/2767-9764.c.7635367"},"language":"en","primary_location":{"id":"doi:10.1158/2767-9764.c.7635367","doi":"https://doi.org/10.1158/2767-9764.c.7635367","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.c.7635367","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/2767-9764.c.7635367","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5056197830","display_name":"Xiaoxiao Sun","orcid":"https://orcid.org/0000-0002-9689-9385","observed_orcids":["https://orcid.org/0000-0002-9689-9385"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiaoxiao Sun","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9689-9385","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013534934","display_name":"Karl Kumbier","orcid":"https://orcid.org/0000-0001-6521-1173","observed_orcids":["https://orcid.org/0000-0001-6521-1173"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Karl Kumbier","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6521-1173","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112722365","display_name":"Savitha Gayathri","orcid":"https://orcid.org/0009-0006-0421-3451","observed_orcids":["https://orcid.org/0009-0006-0421-3451"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Savitha Gayathri","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0006-0421-3451","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030364434","display_name":"Veronica Steri","orcid":"https://orcid.org/0000-0003-2499-6618","observed_orcids":["https://orcid.org/0000-0003-2499-6618"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Veronica Steri","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2499-6618","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015397650","display_name":"Lani F. Wu","orcid":"https://orcid.org/0000-0002-0052-7537","observed_orcids":["https://orcid.org/0000-0002-0052-7537"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lani F. Wu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0052-7537","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5072455858","display_name":"Steven J. Altschuler","orcid":"https://orcid.org/0000-0001-9142-0796","observed_orcids":["https://orcid.org/0000-0001-9142-0796"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Steven J. Altschuler","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9142-0796","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.7764000296592712,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.7764000296592712,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13157","display_name":"Cancer-related gene regulation","score":0.2134999930858612,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/prmt1","display_name":"PRMT1","score":1.0},{"id":"https://openalex.org/keywords/protein-arginine-methyltransferase","display_name":"protein arginine methyltransferase","score":0.8209999799728394},{"id":"https://openalex.org/keywords/lung-cancer","display_name":"lung cancer","score":0.8500000238418579},{"id":"https://openalex.org/keywords/egfr-mutation","display_name":"EGFR mutation","score":0.8970000147819519},{"id":"https://openalex.org/keywords/kras-g12c","display_name":"KRAS G12C","score":0.9120000004768372},{"id":"https://openalex.org/keywords/tumor-recurrence","display_name":"tumor recurrence","score":0.9860000014305115},{"id":"https://openalex.org/keywords/stat1-signaling","display_name":"STAT1 signaling","score":0.800000011920929},{"id":"https://openalex.org/keywords/prmt4","display_name":"PRMT4","score":0.9190000295639038},{"id":"https://openalex.org/keywords/prmt6","display_name":"PRMT6","score":1.0},{"id":"https://openalex.org/keywords/jak-stat-signaling","display_name":"JAK/STAT signaling","score":0.9750000238418579},{"id":"https://openalex.org/keywords/egfr-inhibitors","display_name":"EGFR inhibitors","score":0.6700000166893005},{"id":"https://openalex.org/keywords/kras-inhibitors","display_name":"KRAS inhibitors","score":0.984000027179718},{"id":"https://openalex.org/keywords/prmt1-inhibitors","display_name":"PRMT1 inhibitors","score":0.6129999756813049},{"id":"https://openalex.org/keywords/treatment-resistance","display_name":"treatment resistance","score":0.3659999966621399}],"concepts":[{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.7962256669998169},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.6480490565299988},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5798553824424744},{"id":"https://openalex.org/C2781009140","wikidata":"https://www.wikidata.org/wiki/Q7170389","display_name":"Persistence (discontinuity)","level":2,"score":0.5501823425292969},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.518416166305542},{"id":"https://openalex.org/C143065580","wikidata":"https://www.wikidata.org/wiki/Q3285695","display_name":"Mutant","level":3,"score":0.5171427130699158},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3754340708255768},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.32359886169433594},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3221447765827179},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2782060503959656},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.09035897254943848},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.08124661445617676},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.07603004574775696},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0},{"id":"https://openalex.org/C187320778","wikidata":"https://www.wikidata.org/wiki/Q1349130","display_name":"Geotechnical engineering","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/2767-9764.c.7635367","doi":"https://doi.org/10.1158/2767-9764.c.7635367","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.c.7635367","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/2767-9764.c.7635367","doi":"https://doi.org/10.1158/2767-9764.c.7635367","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.c.7635367","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4405570366","https://openalex.org/W4406630821","https://openalex.org/W4406630787","https://openalex.org/W4406630826","https://openalex.org/W4406630748","https://openalex.org/W4406630786","https://openalex.org/W2570719427","https://openalex.org/W7024987592","https://openalex.org/W3145756892","https://openalex.org/W7148637676"],"abstract_inverted_index":{"Abstract":[0],"Incomplete":[1],"killing":[2],"of":[3,33,95,152],"cancer":[4,14,44,74,121,153,183],"cells":[5,15,45],"undermines":[6],"oncogene-targeting":[7,191],"therapies":[8],"and":[9,52,72,81,103,185],"drives":[10],"disease":[11],"relapse.":[12],"Eliminating":[13,161],"that":[16,29,93,110],"persist":[17,57],"during":[18],"treatment":[19,24,170],"is":[20,116,165],"crucial":[21,166],"for":[22,167,177],"improving":[23],"outcomes.":[25],"Here,":[26],"we":[27,91,108],"discovered":[28],"a":[30,129,137,149,175],"specific":[31],"isoform":[32,147],"type":[34,98],"I":[35,99],"protein":[36],"arginine":[37],"methyltransferases":[38],"(PRMT),":[39],"namely,":[40],"PRMT1,":[41],"enables":[42],"lung":[43,120],"with":[46,65,123,132],"EGFR":[47,66],"or":[48,67,157],"KRASG12C":[49,68],"driver":[50],"mutations":[51],"high":[53],"STAT1":[54],"activity":[55],"to":[56,113,181],"through":[58],"targeted":[59],"drug":[60],"treatments.":[61],"PRMT1":[62,112,146],"knockdown,":[63],"combined":[64],"inhibitors,":[69],"decreased":[70],"persistence":[71,115,154],"delayed":[73],"cell":[75,78],"regrowth":[76],"across":[77],"line":[79],"models":[80,122],"significantly":[82],"prolonged":[83],"tumor":[84],"regression":[85],"in":[86,119,155,190],"xenograft":[87],"models.":[88],"In":[89],"contrast,":[90],"found":[92,109],"knockdown":[94],"two":[96],"other":[97],"PRMT":[100],"isoforms,":[101],"PRMT4":[102],"PRMT6,":[104],"increased":[105],"persistence.":[106],"Finally,":[107],"targeting":[111],"reduce":[114],"more":[117,187],"effective":[118],"intact":[124],"versus":[125],"deleted":[126],"chromosome":[127],"5q31.1,":[128],"region":[130],"enriched":[131],"JAK-STAT":[133],"pathway":[134],"genes,":[135],"suggesting":[136],"potential":[138],"stratification":[139],"criterion.":[140],"Together,":[141],"our":[142],"study":[143,173],"pinpoints":[144],"the":[145],"as":[148],"critical":[150],"vulnerability":[151],"EGFR-":[156],"KRASG12C-targeted":[158],"therapies.":[159,192],"Significance:":[160],"\u201cpersisters\u201d":[162],"before":[163],"relapse":[164],"achieving":[168],"durable":[169,188],"efficacy.":[171],"This":[172],"provides":[174],"rationale":[176],"developing":[178],"PRMT1-selective":[179],"inhibitors":[180],"target":[182],"persisters":[184],"achieve":[186],"outcomes":[189]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2025-01-22T00:00:00"}